← Back to Search

Iodide Supplement

SSKI (Potassium Iodide) for Graves Disease

Phase 3

Waitlist Available

Led By Jennifer Kuo, MD

Research Sponsored by Columbia University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up from baseline to immediately before surgery

Awards & highlights

Study Summary

This trial will test whether SSKI can reduce the number of blood vessels around the thyroid in people with Graves' disease, potentially making surgery more successful.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ from baseline to immediately before surgery

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~from baseline to immediately before surgery

This trial's timeline: 3 weeks for screening, Varies for treatment, and from baseline to immediately before surgery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Vascular Flow from Baseline

Trial Design

2Treatment groups

Active Control

Group I: SSKI (Potassium Iodide)Active Control1 Intervention

Participants randomized to receive 7 days of pre-operative SSKI

Group II: NO SSKIActive Control1 Intervention

Participants randomized to not receive any drug pre-operative

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Columbia UniversityLead Sponsor

1,433 Previous Clinical Trials

2,447,780 Total Patients Enrolled

Jennifer Kuo, MDPrincipal Investigator - Columbia University

Hudson Valley Hospital Center, New York Presbyterian Hospital-Allen Hospital, The, New York Presbyterian Hospital-Columbia Presbyterian Center, New York Presbyterian Hospital/Weill Cornell Medical Center, NewYork-Presbyterian/Lawrence Hospital

Columbia University College Of Physicians And Surgeons (Medical School)

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any other examples in the medical literature of SSKI (Potassium Iodide) being used?

"At this moment, there are five ongoing clinical trials research SSKI (Potassium Iodide). Out of those five, two are in Phase 3. Most investigations for SSKI are based in Sevilla and Vizcaya; however, there are 25 total locations running these tests."

Answered by AI

Has the FDA cleared SSKI (Potassium Iodide) for use?

"There is both efficacy and safety data available for SSKI (Potassium Iodide), which has been gathered from multiple rounds of clinical trials. Therefore, it received a score of 3."

Answered by AI

How many patients are being enrolled in this study?

"From what is published on clinicaltrials.gov, it seems that this particular trial is still recruiting patients. The first posting was on February 10th, 2015 with the most recent update being November 10th, 2021. They are looking for 50 individuals total at a single location."

Answered by AI

How does SSKI (Potassium Iodide) help patients?

"SSKI (Potassium Iodide) is most often used in the treatment of thyroid cancer, but it can also be helpful for patients experiencing acute radiation sickness or those who may be subject to radiation poisoning. Additionally, SSKI provides essential nutrients that can help supplement a person's diet."

Answered by AI

Are there any vacancies in this research program for new participants?

"The info available on clinicaltrials.gov leads us to believe that this study is still enrolling patients. The trial was announced on February 10th, 2015 and has since been updated on November 10th, 2021. They are looking for 50 individuals total from a single location."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Does Potassium Iodide (SSKI) Reduce Vascularity in Graves' Thyroidectomy?

Jennifer Kuo 2015. "Does Potassium Iodide (SSKI) Reduce Vascularity in Graves' Thyroidectomy?". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04080505.